Dr Sandra Stefanovic-Barrett

Sandra obtain bachelors degree in Molecular Biology at University of Belgrade and moved to UK to do PhD in Institute for Animal Health, Pirbright laboratories. During the PhD she worked on cellular changes induced by ASFV (African Swine Fever Virus). Her first postdoc was in NIH, Bethesda,USA in laboratory of Dr Ramanujan Hegde during which time she published the discovery of novel pathway for membrane protein insertion. Next two postdoctoral positions were back in UK, in Babraham and University of Cambridge respectively. Her work at University of Cambridge, CIMR focused on degron induced proteasome degradation at the cytosolic face of endoplasmic reticulum. She has joined Cellular Assay Development group in AstraZeneca in April, 2019.